Suspension of trading

Income Statement Acorda Therapeutics OTC Markets

Stocks

ACOR

US00484M7002

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-10.00%	-99.91%

24-08-13	First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc.	CI
24-08-07	Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc.	CI

4d99f0690a604f6ad7a1ba1796cacc5._t1op79acNWxjgY6ceGxNNVoG8etsxJ-TkcoquB8Frg.kbwvlc8CJZHeo3YPOLHVUONddYCZxnkKGgttxthLUuG8qgfr2RgAk_zRcQ

Published financial data: ACORDA THERAPEUTICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	192M	153M	129M	119M	118M
Total Revenues	192M	153M	129M	119M	118M
Cost of Goods Sold, Total	34.85M	56.18M	50.61M	36.14M	20.44M
Gross Profit	158M	96.78M	78.46M	82.43M	97.2M
Selling General & Admin Expenses, Total	190M	153M	119M	106M	89.7M
R&D Expenses	58.68M	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	25.64M	30.76M	30.76M	30.76M	30.76M
Other Operating Expenses	-	-	-	-12.55M	-
Other Operating Expenses, Total	274M	183M	150M	124M	120M
Operating Income	-117M	-86.55M	-71.3M	-41.78M	-23.26M
Interest Expense, Total	-21.87M	-30.57M	-30.04M	-30.2M	-31.53M
Interest And Investment Income	4.17M	816K	5K	1.91M	530K
Net Interest Expenses	-17.7M	-29.76M	-30.03M	-28.29M	-31M
Currency Exchange Gains (Loss)	-	-	-	-8K	-288K
Other Non Operating Income (Expenses)	13K	40.13M	1.15M	1.29M	51K
EBT, Excl. Unusual Items	-134M	-76.19M	-100M	-68.8M	-54.5M
Restructuring Charges	-4.4M	-343K	-6M	-251K	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-278M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-57.9M	-	-	171K
Asset Writedown	-	-4.13M	-	-	-251M
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	142M	30.89M	-2.9M	33.8M	9.63M
EBT, Incl. Unusual Items	-274M	-108M	-109M	-35.25M	-296M
Income Tax Expense	-1.28M	-8.07M	-5.12M	30.67M	-43.17M
Earnings From Continuing Operations	-273M	-99.59M	-104M	-65.92M	-253M
Net Income to Company	-273M	-99.59M	-104M	-65.92M	-253M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-273M	-99.59M	-104M	-65.92M	-253M
Net Income to Common Incl Extra Items	-273M	-99.59M	-104M	-65.92M	-253M
Net Income to Common Excl. Extra Items	-273M	-99.59M	-104M	-65.92M	-253M
Per Share Items
Net EPS - Basic	-689.42	-246.4	-195.75	-66.9	-203.59
Basic EPS - Continuing Operations	-689.42	-246.4	-195.75	-66.9	-203.59
Basic Weighted Average Shares Outstanding	396K	404K	531K	985K	1.24M
Net EPS - Diluted	-690	-246.4	-195.8	-66.9	-203.59
Diluted EPS - Continuing Operations	-690	-246.4	-195.8	-66.9	-203.59
Diluted Weighted Average Shares Outstanding	396K	404K	531K	985K	1.24M
Normalized Basic EPS	-211.99	-117.8	-117.9	-43.64	-27.43
Normalized Diluted EPS	-211.99	-117.8	-117.9	-43.64	-27.43
Supplemental Items
EBITDA	-82.63M	-45.66M	-37.65M	-9.08M	8.4M
EBITA	-90.97M	-55.79M	-40.54M	-11.02M	7.5M
EBIT	-117M	-86.55M	-71.3M	-41.78M	-23.26M
EBITDAR	-69.56M	-33.3M	-26.61M	-3.22M	10.38M
Total Revenues (As Reported)	192M	153M	129M	119M	118M
Effective Tax Rate - (Ratio)	0.47	7.5	4.69	-87.01	14.58
Current Domestic Taxes	621K	-11.59M	-48K	358K	968K
Current Foreign Taxes	75K	65K	113K	37K	71K
Total Current Taxes	696K	-11.52M	65K	395K	1.04M
Deferred Domestic Taxes	-1.98M	4.37M	-5.12M	30.27M	-44.21M
Deferred Foreign Taxes	-	-926K	-62K	-	-
Total Deferred Taxes	-1.98M	3.45M	-5.18M	30.27M	-44.21M
Normalized Net Income	-83.93M	-47.62M	-62.61M	-43M	-34.06M
Interest on Long-Term Debt	21.87M	30.57M	30.04M	30.2M	31.53M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	60.08M	23.01M	10.42M	5.8M	5.15M
Net Rental Expense, Total	13.07M	12.36M	11.04M	5.86M	1.97M
Imputed Operating Lease Interest Expense	7.05M	11M	11.27M	7.68M	2.74M
Imputed Operating Lease Depreciation	6.02M	1.35M	-233K	-1.83M	-763K
Stock-Based Comp., COGS (Total)	624K	2.08M	713K	75K	11K
Stock-Based Comp., R&D Exp. (Total)	2.81M	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	10.81M	6.02M	2.28M	1.42M	467K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	14.25M	8.1M	3M	1.5M	478K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	62.08M	71.37M	45.63M	37.54M	29.98M
Short Term Investments	63.75M	-	-	-	-
Total Cash And Short Term Investments	126M	71.37M	45.63M	37.54M	29.98M
Accounts Receivable, Total	22.08M	20.19M	17M	13.87M	17.3M
Total Receivables	22.08M	20.19M	17M	13.87M	17.3M
Inventory	25.22M	28.68M	18.55M	12.75M	16.16M
Prepaid Expenses	11.57M	14.81M	6.57M	4.31M	5.21M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	12.84M	12.92M	13.4M	6.88M	381K
Other Current Assets, Total	3.56M	73.37M	999K	6.76M	5.77M
Total Current Assets	201M	221M	102M	82.12M	74.79M
Gross Property Plant And Equipment	230M	61.77M	46.13M	14.64M	11.88M
Accumulated Depreciation	-64.48M	-36.02M	-35M	-6.76M	-5.58M
Net Property Plant And Equipment	166M	25.74M	11.13M	7.89M	6.3M
Goodwill	-	-	-	-	-
Other Intangibles, Total	402M	367M	336M	305M	22.99M
Deferred Tax Assets Long-Term	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	30.3M	18.62M	6.2M	503K	4.44M
Total Assets	800M	633M	455M	396M	109M
Liabilities
Accounts Payable, Total	26.26M	12.16M	10.84M	9.81M	13.37M
Accrued Expenses, Total	39.08M	38.17M	26.75M	23.68M	24.31M
Current Portion of Long-Term Debt	11.44M	77.36M	4.46M	-	186M
Current Portion of Leases	7.75M	7.94M	8.19M	1.54M	1.59M
Unearned Revenue Current, Total	-	-	-	384K	227K
Other Current Liabilities	1.87M	1.62M	3.78M	2.53M	2.13M
Total Current Liabilities	86.38M	137M	54.02M	37.95M	228M
Long-Term Debt	232M	173M	179M	167M	-
Long-Term Leases	23M	17.2M	4.09M	4.34M	3.17M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	9.58M	19.12M	13.93M	44.2M	-
Other Non Current Liabilities	138M	48.46M	53.62M	48.45M	35.54M
Total Liabilities	489M	395M	304M	302M	266M
Common Stock, Total	48K	9K	13K	24K	1K
Additional Paid In Capital	979M	1.01B	1.02B	1.03B	1.03B
Retained Earnings	-667M	-766M	-870M	-936M	-1.19B
Treasury Stock	-638K	-638K	-638K	-638K	-638K
Comprehensive Income and Other	-1.17M	-2.8M	-1.02M	628K	1.42M
Total Common Equity	311M	238M	151M	93.62M	-158M
Total Equity	311M	238M	151M	93.62M	-158M
Total Liabilities And Equity	800M	633M	455M	396M	109M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	400K	474K	662K	1.22M	1.24M
ECS Total Common Shares Outstanding	398K	474K	662K	1.22M	1.24M
Book Value / Share	781.92	502.54	228.23	76.94	-127.17
Tangible Book Value	-91.51M	-129M	-185M	-211M	-181M
Tangible Book Value Per Share	-230.21	-272.49	-279.13	-173.78	-145.68
Total Debt	274M	275M	195M	173M	191M
Net Debt	148M	204M	150M	135M	161M
Debt Equivalent Oper. Leases	105M	98.84M	88.3M	46.84M	15.78M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.75M	3.43M	3.34M	6.21M	4.18M
Inventories - Work In Process, Total	13.51M	6.6M	-	-	2.49M
Inventories - Finished Goods, Total	9.96M	18.64M	15.21M	6.54M	9.49M
Machinery, Total	61.38M	27.8M	24.06M	7.6M	5.64M
Full Time Employees	344	167	118	111	102
Part Time Employees	-	1	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	682K	1.27M	1.01M	842K	962K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-273M	-99.59M	-104M	-65.92M	-253M
Depreciation & Amortization - CF	8.34M	10.14M	2.89M	1.94M	902K
Amortization of Goodwill and Intangible Assets - (CF)	25.64M	30.76M	30.76M	30.76M	30.76M
Depreciation & Amortization, Total	33.97M	40.9M	33.65M	32.71M	31.67M
Amortization of Deferred Charges, Total - (CF)	16.32M	16.82M	16.58M	17.02M	19.11M
(Gain) Loss From Sale Of Asset	-	57.7M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.65M	562K	-	-	-
Asset Writedown & Restructuring Costs	278M	4.13M	-	-	251M
Stock-Based Compensation (CF)	14.25M	8.1M	3M	1.49M	478K
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-154M	-77.67M	-15.55M	-7.93M	-52.88M
Change In Accounts Receivable	1.35M	1.89M	3.19M	2.58M	-3.43M
Change In Inventories	3.79M	-3.46M	7.86M	5.8M	-3.4M
Change In Accounts Payable	-60.56M	-8.97M	1.11M	-7.36M	884K
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	14.02M	-1.42M	12.78M	676K	-4.88M
Cash from Operations	-128M	-61.01M	-41.35M	-20.92M	-13.98M
Capital Expenditure	-90.43M	-4.39M	-165K	-136K	-264K
Sale of Property, Plant, and Equipment	-	-	73.97M	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-26K	-	-
Investment in Marketable and Equity Securities, Total	89.92M	63.75M	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-505K	59.36M	73.78M	-136K	-264K
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-55.81M	-597K	-69.66M	-	-
Total Debt Repaid	-55.81M	-597K	-69.66M	-	-
Issuance of Common Stock	24K	-	-	-	-
Repurchase of Common Stock	-91K	-	-	-	-
Other Financing Activities, Total	-4.67M	-1.07M	-	-	-
Cash from Financing	-60.55M	-1.67M	-69.66M	-	-
Foreign Exchange Rate Adjustments	62K	1.02M	-447K	512K	188K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-189M	-2.3M	-37.67M	-20.55M	-14.06M
Supplemental Items
Cash Interest Paid	6.06M	6.67M	6K	7.16M	12.42M
Cash Income Tax Paid (Refund)	2.79M	251K	50K	199K	804K
Levered Free Cash Flow	-169M	-102M	72.58M	13.07M	20.14M
Unlevered Free Cash Flow	-171M	-99.03M	75.07M	15.02M	20.74M
Change In Net Working Capital	56.18M	89.95M	-82.88M	-6.97M	-3.4M
Net Debt Issued / Repaid	-55.81M	-597K	-69.66M	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-6.94	-7.55	-8.19	-6.14	-5.77
Return on Total Capital	-9.28	-9.85	-10.37	-8.52	-9.71
Return On Equity %	-59.16	-36.3	-53.43	-53.86	786.07
Return on Common Equity	-59.16	-36.3	-53.43	-53.86	786.07
Margin Analysis
Gross Profit Margin %	81.89	63.27	60.79	69.52	82.63
SG&A Margin	98.67	99.74	92.2	89.41	76.25
EBITDA Margin %	-42.95	-29.85	-29.17	-7.65	7.14
EBITA Margin %	-47.28	-36.47	-31.41	-9.3	6.38
EBIT Margin %	-60.6	-56.58	-55.24	-35.24	-19.78
Income From Continuing Operations Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Net Income Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Net Avail. For Common Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Normalized Net Income Margin	-43.62	-31.13	-48.51	-36.27	-28.96
Levered Free Cash Flow Margin	-87.63	-66.5	56.23	11.02	17.13
Unlevered Free Cash Flow Margin	-88.7	-64.74	58.16	12.67	17.63
Asset Turnover
Asset Turnover	0.18	0.21	0.24	0.28	0.47
Fixed Assets Turnover	1.7	1.6	7	12.47	16.58
Receivables Turnover (Average Receivables)	8.46	7.24	6.94	7.68	7.55
Inventory Turnover (Average Inventory)	1.29	2.08	2.14	2.31	1.41
Short Term Liquidity
Current Ratio	2.33	1.61	1.89	2.16	0.33
Quick Ratio	1.71	0.67	1.16	1.35	0.21
Operating Cash Flow to Current Liabilities	-1.48	-0.44	-0.77	-0.55	-0.06
Days Sales Outstanding (Average Receivables)	43.17	50.58	52.59	47.51	48.35
Days Outstanding Inventory (Average Inventory)	284.02	175.56	170.3	158.08	258.16
Average Days Payable Outstanding	441.42	117.87	103.7	124.24	177.48
Cash Conversion Cycle (Average Days)	-114.23	108.27	119.2	81.35	129.03
Long Term Solvency
Total Debt/Equity	88.16	115.65	129.29	184.7	-120.85
Total Debt / Total Capital	46.85	53.63	56.39	64.87	579.51
LT Debt/Equity	81.99	79.8	120.92	183.05	-2
Long-Term Debt / Total Capital	43.57	37.01	52.74	64.3	9.61
Total Liabilities / Total Assets	61.13	62.39	66.82	76.33	245.55
EBIT / Interest Expense	-5.33	-2.83	-2.37	-1.38	-0.74
EBITDA / Interest Expense	-3.18	-1.09	-0.89	-0.11	0.33
(EBITDA - Capex) / Interest Expense	-7.31	-1.23	-0.89	-0.11	0.32
Total Debt / EBITDA	-3.94	-8.26	-7.34	-53.68	18.4
Net Debt / EBITDA	-2.13	-6.12	-5.63	-42.03	15.51
Total Debt / (EBITDA - Capex)	-1.71	-7.3	-7.3	-51.51	18.88
Net Debt / (EBITDA - Capex)	-0.93	-5.41	-5.59	-40.33	15.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-59.19	-20.5	-15.62	-8.14	-0.79
Gross Profit, 1 Yr. Growth %	-57.85	-2.11	-18.93	5.05	17.49
EBITDA, 1 Yr. Growth %	-178.28	-44.75	-17.54	-75.89	-196.84
EBITA, 1 Yr. Growth %	-194.28	-38.67	-27.34	-72.81	-169.96
EBIT, 1 Yr. Growth %	-223.02	-25.77	-17.62	-41.39	-43.92
Earnings From Cont. Operations, 1 Yr. Growth %	-910.42	-63.51	4.38	-36.59	283.6
Net Income, 1 Yr. Growth %	-910.42	-63.51	4.38	-36.59	283.6
Normalized Net Income, 1 Yr. Growth %	-275.04	-43.27	31.49	-31.33	-20.43
Diluted EPS Before Extra, 1 Yr. Growth %	-909.86	-64.22	-20.54	-65.83	212.1
Accounts Receivable, 1 Yr. Growth %	-5.75	-8.56	-15.8	-18.44	24.75
Inventory, 1 Yr. Growth %	-13.07	13.7	-35.32	-31.25	26.69
Net Property, Plant and Equip., 1 Yr. Growth %	174.26	-84.49	-56.76	-29.13	-20.15
Total Assets, 1 Yr. Growth %	-38.47	-20.89	-28.01	-13.15	-72.57
Tangible Book Value, 1 Yr. Growth %	-7.24	41	43.26	14.4	-14.43
Common Equity, 1 Yr. Growth %	-49.21	-23.44	-36.49	-38.05	-268.72
Cash From Operations, 1 Yr. Growth %	-185	-52.4	-32.22	-49.4	-33.17
Capital Expenditures, 1 Yr. Growth %	171.32	-95.15	-96.24	-17.58	94.12
Levered Free Cash Flow, 1 Yr. Growth %	-258.22	-39.67	-171.35	-81.99	51.94
Unlevered Free Cash Flow, 1 Yr. Growth %	-263.72	-41.97	-175.8	-79.99	36.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-42.81	-43.04	-18.1	-11.96	-4.53
Gross Profit, 2 Yr. CAGR %	-42.49	-49.12	-10.92	-7.71	11.3
EBITDA, 2 Yr. CAGR %	-21.96	-34.24	-32.5	-55.41	-52.76
EBITA, 2 Yr. CAGR %	-18.28	-23.96	-33.25	-55.55	-56.99
EBIT, 2 Yr. CAGR %	1.83	-4.44	-21.8	-30.52	-42.88
Earnings From Cont. Operations, 2 Yr. CAGR %	10.55	71.96	-38.29	-18.65	55.96
Net Income, 2 Yr. CAGR %	10.55	71.96	-38.29	-18.65	55.96
Normalized Net Income, 2 Yr. CAGR %	19.92	-0.35	-13.63	-4.97	-26.24
Diluted EPS Before Extra, 2 Yr. CAGR %	8.77	70.06	-46.68	-47.9	1.97
Accounts Receivable, 2 Yr. CAGR %	-47.92	-7.16	-12.26	-17.13	0.87
Inventory, 2 Yr. CAGR %	-17.99	-0.58	-14.24	-33.32	-6.67
Net Property, Plant and Equip., 2 Yr. CAGR %	112.75	-34.78	-74.1	-44.64	-24.77
Total Assets, 2 Yr. CAGR %	-18.3	-30.23	-24.53	-20.93	-51.19
Tangible Book Value, 2 Yr. CAGR %	-31.88	14.37	42.12	28.02	-1.06
Common Equity, 2 Yr. CAGR %	-22.69	-37.64	-30.27	-37.27	2.23
Cash From Operations, 2 Yr. CAGR %	14.87	-36.39	-43.2	-41.44	-41.84
Capital Expenditures, 2 Yr. CAGR %	157.03	-63.71	-95.73	-82.4	26.49
Levered Free Cash Flow, 2 Yr. CAGR %	38.73	-2.3	-34.39	-64.15	-47.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	39.96	-2.53	-33.68	-61.05	-47.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-28.19	-36.17	-35.07	-14.9	-8.38
Gross Profit, 3 Yr. CAGR %	-27.38	-41.21	-40.57	-5.88	0.14
EBITDA, 3 Yr. CAGR %	91.32	-30.45	-29.09	-52.11	-43.12
EBITA, 3 Yr. CAGR %	110.29	-25.73	-25.1	-50.52	-48.77
EBIT, 3 Yr. CAGR %	128.44	-8.35	-9.05	-28.97	-35.46
Earnings From Cont. Operations, 3 Yr. CAGR %	97.18	-23.6	45.6	-37.73	36.42
Net Income, 3 Yr. CAGR %	99.04	-23.6	45.6	-37.73	36.42
Normalized Net Income, 3 Yr. CAGR %	110.04	-6.56	9.3	-19.99	-10.56
Diluted EPS Before Extra, 3 Yr. CAGR %	95.9	-24.96	31.96	-54.03	-6.16
Accounts Receivable, 3 Yr. CAGR %	-24.95	-37.17	-10.14	-14.37	-5.03
Inventory, 3 Yr. CAGR %	-16.38	-8.55	-13.86	-20.33	-17.41
Net Property, Plant and Equip., 3 Yr. CAGR %	69.13	-11.12	-43.13	-63.78	-37.45
Total Assets, 3 Yr. CAGR %	-15.86	-19.17	-29.5	-20.91	-44.44
Tangible Book Value, 3 Yr. CAGR %	-36.57	-13.19	23.28	32.21	11.93
Common Equity, 3 Yr. CAGR %	-22.36	-22.94	-37.26	-32.97	-12.77
Cash From Operations, 3 Yr. CAGR %	62.9	-14.36	-35.03	-45.35	-38.8
Capital Expenditures, 3 Yr. CAGR %	144.43	-31.55	-82.96	-88.55	-60.82
Levered Free Cash Flow, 3 Yr. CAGR %	28.48	5.11	-12.02	-57.36	-41.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.67	4.37	-10.36	-55.52	-40.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-13.68	-20.86	-24.31	-27.41	-24.24
Gross Profit, 5 Yr. CAGR %	-13.26	-24.7	-28.21	-29.59	-23.62
EBITDA, 5 Yr. CAGR %	8.86	-5.41	26.12	-41.78	-39.72
EBITA, 5 Yr. CAGR %	14.82	4.26	32.89	-39.52	-40
EBIT, 5 Yr. CAGR %	20.67	13.83	48.78	-17.96	-24.49
Earnings From Cont. Operations, 5 Yr. CAGR %	72.89	55.21	23.9	-21.66	49.66
Net Income, 5 Yr. CAGR %	72.89	55.21	24.6	-21.66	49.66
Normalized Net Income, 5 Yr. CAGR %	29.27	19.96	47.21	-5.93	-6.61
Diluted EPS Before Extra, 5 Yr. CAGR %	68.77	52.37	16.36	-35.15	19.03
Accounts Receivable, 5 Yr. CAGR %	-7.27	-8.49	-20.11	-29.81	-5.89
Inventory, 5 Yr. CAGR %	-1.23	-4.7	-15.53	-19.41	-11.05
Net Property, Plant and Equip., 5 Yr. CAGR %	29.21	-8.53	-20.16	-26.45	-36.4
Total Assets, 5 Yr. CAGR %	-5.57	-10.65	-19.44	-19.88	-39.14
Tangible Book Value, 5 Yr. CAGR %	3.92	62.27	-12.41	1.4	12.9
Common Equity, 5 Yr. CAGR %	-10.47	-16.97	-25.63	-29.03	-23.73
Cash From Operations, 5 Yr. CAGR %	11.42	9.65	6.88	-26.44	-37.85
Capital Expenditures, 5 Yr. CAGR %	77.84	-5.81	-51.57	-60.24	-62
Levered Free Cash Flow, 5 Yr. CAGR %	14.64	27.76	-1.81	-31.65	-28.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.51	26.16	-1.29	-29.64	-27.6